MapLight Therapeutics, Inc. Earnings Per Share (Basic)
MapLight Therapeutics, Inc. (MPLT) reported Earnings Per Share (Basic) of -$1.32 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- MapLight Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$1.32.
- MapLight Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$1.34.
- MapLight Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$2.45.
- MapLight Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$37.18.
- MapLight Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$18.56.
- MapLight Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$105.38.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.32 10-Q · filed 2026-08-13 | -$2.66 10-Q · filed 2026-08-13 | -$4.88 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$7.42 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2026-03-31 | -$1.34 10-Q · filed 2026-05-14 | -$3.61 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$6.48 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$10.07 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-12-31 | -$2.45 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$6.56 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$12.26 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$18.56 10-K · filed 2026-03-26 |
| 2025-09-30 | -$37.18 10-Q · filed 2025-12-04 | -$76.26 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$105.70 10-Q · filed 2025-12-04 | -$133.75 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-06-30 | -$39.11 10-Q · filed 2026-08-13 | -$68.46 10-Q · filed 2026-08-13 | -$96.41 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$121.52 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-03-31 | -$29.33 10-Q · filed 2026-05-14 | -$57.28 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$82.37 derived: net income ÷ weighted average shares · filed 2026-08-13 | |
| 2024-12-31 | -$27.94 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$53.03 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$105.38 10-K · filed 2026-03-26 | |
| 2024-09-30 | -$25.08 10-Q · filed 2025-12-04 | -$77.37 10-Q · filed 2025-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |